This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
WellCare Health (WCG) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
WellCare Health's (WCG) third-quarter results reflect improved revenues.
Community Health's (CYH) Q3 Loss Narrower Than Expected
by Zacks Equity Research
Community Health's (CYH) third-quarter results reflect decreased admissions.
Molina Healthcare (MOH) Q3 Earnings Surpass, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings benefit from lower expenses.
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results gain traction from better revenues.
Universal Health's (UHS) Earnings Lag in Q3, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are hurt by high operating expenses.
Company News For Oct 23, 2019
by Zacks Equity Research
Companies In The News Are: PG,UTX,NEE,CNC
Centene (CNC) Catches Eye: Stock Jumps 6.5%
by Zacks Equity Research
Centene (CNC) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Centene's (CNC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Centene's (CNC) third-quarter earnings gain traction from higher revenues.
Centene's (CNC) Q3 Earnings and Revenue Beat Estimates
by Zacks Equity Research
Centene's (CNC) third quarter earnings reflect growth on the back of higher revenues.
What's in the Cards for Centene's (CNC) Earnings in Q3?
by Zacks Equity Research
Centene's (CNC) third-quarter earnings are likely to have grown on the back of solid revenues.
Centene (CNC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $45.54 in the latest trading session, marking a +0.73% move from the prior day.
Centene (CNC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Centene (CNC) closed at $44.09, marking a +0.62% move from the previous day.
Centene's Carolina Complete Health Wins Medicaid Contract
by Zacks Equity Research
Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.
UnitedHealth Expands Medicare Offerings in New Counties
by Zacks Equity Research
UnitedHealth (UNH) is offering Medicare Advantage plans in new counties to reach a greater population of retirees.
Humana Penetrates Further in New Jersey Via PPO, HMO Plan
by Zacks Equity Research
Humana (HUM) expands its footprint in New Jersey to facilitate the locals with better healthcare solutions.
Health Insurers Hope to Gain From Executive Order on Medicare
by Sapna Bagaria
President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.
Cigna Offers 2020 Medicare Plans with Supplemental Benefits
by Sapna Bagaria
Cigna (CI) is expanding its Medicare Advantage plans across states and counties along with supplemental benefits
Centene (CNC) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $42.73, moving -0.05% from the previous trading session.
WellCare's Unit to Divest Medicaid Health Plans to Anthem
by Zacks Equity Research
WellCare's (WCG) subsidiary to sell specific Medicaid health plans to Anthem prior to its merger with Centene.
Centene (CNC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $45.33 in the latest trading session, marking a -0.98% move from the prior day.
UnitedHealth to Offer Medicare Advantage Plan in Bay Area
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Centene (CNC) Stock Moves 0.98%: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $46.45 in the latest trading session, marking a +0.98% move from the prior day.
Humana and Seniorlink to Serve Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) collaborates with Seniorlink to unveil Virtual Care Team pilot for offering its Medicare Advantage members an improved healthcare management.
Strategic Acquisitions Aid Revenue Growth at Ensign Group
by Zacks Equity Research
Ensign Group's (ENSG) series of strategic buyouts aids its top line and the trend is expected to continue.
3 Reasons Growth Investors Will Love Centene (CNC)
by Zacks Equity Research
Centene (CNC) could produce exceptional returns because of its solid growth attributes.